Satralizumab

ATC L04AC19 · 9 markets · 10 records

Satralizumab 9 markets · 10 records Forms

AU 2 records · 2 strengths

  • 120 mginjectionENSPRYNG satralizumab 120 mg/1 mL solution for injection in pre-filled syringe also in US·ES·TW unknown

Records without a stated strength · 1 Enspryng

US 1 records · 1 strengths

GB 1 records · 1 strengths

  • 120 mg/1 mLinjectionEnspryng 120mg/1ml solution for injection pre-filled syringes

CA 1 records · 1 strengths

SG 1 records · 1 strengths

  • 120 mg/mLinjectionENSPRYNG SOLUTION FOR INJECTION IN PREFILLED SYRINGE 120MG/1ML

ES 1 records · 1 strengths

TW 1 records · 1 strengths

HK 1 records · 1 strengths

    Records without a stated strength · 1 ENSPRYNG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 120MG/1ML

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 Enspryng

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.